The Food and Drug Administration (FDA) announced the approval of the weight loss drug Zepbound, generically known as ...

FDA has approved the first prescription drug, Zepbound, for treating moderate to severe obstructive sleep apnea (OSA) in ...

Attorney General Kwame Raoul is warning Illinois residents seeking GLP-1 medications – Ozempic, Wegovy, Mounjaro, Zepbound ...

Zepbound led to an average weight loss of 20.2 percent compared to ... And of course, pairing the medication with a healthy diet and exercise will help deliver the best results.

In 2024, new medicines changed how we think about healthy weight loss—but psychological factors remain just as important as ...

The decision will largely prevent compounding pharmacies from making and selling compounded versions of the drug in the next ...

The mega-blockbuster weight loss GLP-1 drug is now also approved to treat obstructive sleep apnea in adults with obesity, in ...

Eli Lilly's Zepbound is set to dominate the global obesity market, offering new hope with its groundbreaking treatment for ...

HFpEF refers to when the heart is unable to pump enough blood to meet the body’s needs. Eli Lilly said the condition is linked to a “high burden” of symptoms and physical limitations that affect a ...

The FDA approved a new drug treatment for obstructive sleep apnea that improves the condition through weight loss. Sleep expert Dr. Wendy Troxel discusses the impact of the new development.

The Food and Drug Administration announced that branded tirzepatide, the active ingredient in Eli Lilly's weight loss drug Zepbound ... a healthier diet and exercise. She said she initially ...